Lantern Pharma Stock Technical Analysis

LTRN Stock  USD 3.83  0.01  0.26%   
As of the 24th of March, Lantern Pharma secures the Mean Deviation of 4.52, risk adjusted performance of 0.0565, and Downside Deviation of 5.33. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lantern Pharma, as well as the relationship between them.

Lantern Pharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lantern, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Lantern
  
Lantern Pharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Lantern Pharma Analyst Consensus

Target PriceAdvice# of Analysts
20.5Strong Buy1Odds
Lantern Pharma current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Lantern analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Lantern stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Lantern Pharma, talking to its executives and customers, or listening to Lantern conference calls.
Lantern Analyst Advice Details
Lantern Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Lantern Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lantern Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Lantern Pharma Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was five with a total number of output elements of fifty-six. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Lantern Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Lantern Pharma Trend Analysis

Use this graph to draw trend lines for Lantern Pharma. You can use it to identify possible trend reversals for Lantern Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Lantern Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Lantern Pharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Lantern Pharma applied against its price change over selected period. The best fit line has a slop of    , which means Lantern Pharma will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.05, which is the sum of squared deviations for the predicted Lantern Pharma price change compared to its average price change.

About Lantern Pharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lantern Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lantern Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lantern Pharma price pattern first instead of the macroeconomic environment surrounding Lantern Pharma. By analyzing Lantern Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lantern Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lantern Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 2025 (projected)
Current Ratio20.9916.1814.5614.43
Net Debt To EBITDA2.581.371.241.62

Lantern Pharma March 24, 2025 Technical Indicators

Most technical analysis of Lantern help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lantern from various momentum indicators to cycle indicators. When you analyze Lantern charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Lantern Pharma March 24, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Lantern stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Lantern Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lantern Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lantern Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lantern Pharma Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.78)
Return On Assets
(0.34)
Return On Equity
(0.53)
The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.